Abstract:<section class="article-section__content"><h3 class="article-section__sub-title section1"> Background</h3><p>The dysferlin gene or the DYSF gene encodes a Ca<sup>2+</sup> dependent phospholipid‐binding protein dysferlin which belongs to the ferlin family and is associated with muscle membrane regeneration and repair. Variants in the DYSF gene are responsible for limb‐girdle muscular dystrophy type 2B (LGMD2B), also called limb‐girdle muscular dystrophy recessive 2 (LGMDR2), a rare subtype of muscular dystrophies with progressive muscle weakness and atrophy. The present study aims to identify the variants responsible for the clinical symptoms of a Chinese patient with limb girdle muscular dystrophies (LGMDs) and to explore the genotype‐phenotype associations of LGMD2B. </p></section><section class="article-section__content"><h3 class="article-section__sub-title section1"> Methods</h3><p>A series of clinical examinations including blood tests, magnetic resonance imaging (MRI) scans for the lower legs, electromyography (EMG) and muscle biopsy were performed on the proband diagnosed with muscular dystrophies. Whole exome sequencing (WES) was conducted to detect the causative variants, followed by Sanger sequencing to validate these variants subsequently.</p></section><section class="article-section__content"><h3 class="article-section__sub-title section1"> Results</h3><p>We identified two compound heterozygous variants in the DYSF gene c.1058T>C, p.(Leu353Pro) in exon 12 and c.1461C>A/p.Cys487* in exon 16 in this proband, which were inherited from the father and mother, respectively. In‐silico analysis for these variants revealed deleterious results by PolyPhen‐2, SIFT, PROVEAN and MutationTaster. In addition, the two compound heterozygous variants in the proband were absent in 100 control individuals with identical ethnic origin from the same region, suggesting these variants may be the pathogenic variants responsible for the LGMD2B phenotypes for this proband.</p></section><section class="article-section__content"><h3 class="article-section__sub-title section1"> Conclusions</h3><p>The present study broadens our understanding of the mutational spectrum of the DYSF gene<i>,</i> which provides a deep insight into further study in LGMDs pathogenesis and accelerates the development of prenatal diagnosis. </p></section>

Clinical, Myopathological and Genetic Mutations Features of Limb Girdle Muscular Dystrophy 2I

Clinical Features and Molecular Genetic Analysis of a Pedigree of Limb Girdle Muscular Dystrophy

Identification of LAMA2 Compound Heterozygous Variants: a Case Report

Asian Patients with Limb Girdle Muscular Dystrophy 2I (LGMD2I)

Limb-girdle Muscular Dystrophy Type 2D: Clinical and Genetic Analysis of a Family

Limb Girdle Muscular Dystrophy 23 Caused by Compound Heterozygous Mutations of LAMA2 Gene

Genetic Variability and Clinical Spectrum of Chinese Patients with Limb‐girdle Muscular Dystrophy Type 2A

Novel Mutations in the C-terminal Region of GMPPB Causing Limb-Girdle Muscular Dystrophy Overlapping with Congenital Myasthenic Syndrome

Magnetic Resonance Imaging Findings in the Muscle Tissue of Patients with Limb Girdle Muscular Dystrophy Type 2I Harboring the Founder Mutation c.545A>G in the FKRP Gene

Compound heterozygous DYSF variants causing limb‐girdle muscular dystrophy type 2B in a Chinese family

Unique Genotype-Phenotype Correlations Within LAMA2-related Limb Girdle Muscular Dystrophy in Chinese Patients

[Analysis of clinical characteristics and genetic variants in two children with Limb-girdle muscular dystrophy autosomal recessive 9 FKRP-related]

The clinical features and TCAP mutation Spectrum in a Chinese cohort of patients with limb-girdle muscular dystrophy R7

Clinical,pathological and Genetic Studies in a Chinese Charcot-Marie-Tooth Disease Type 2 Family

FKRP mutations, including a founder mutation, cause phenotype variability in Chinese patients with dystroglycanopathies

Mutational spectrum of Chinese LGMD patients by targeted next-generation sequencing

Advances in Diagnosis and Treatment of Limb-Girdle Muscular Dystrophy

Clinical spectrum and genetic variations of <i>LMNA</i>-related muscular dystrophies in a large cohort of Chinese patients

The Clinical,pathological Features and Analysis of Mitochondrial DNA Mutation in 8 Cases with Limb-Girdle Mitochon-Drial Myopathy

Genetic Variation Analysis and Treatment Strategy of 20 Patients with Dystrophin Gene Mutations

The Limb-Girdle Muscular Dystrophies